February 2026 – AMETEK Acquires LKC Technologies to Expand Ophthalmic Diagnostic PortfolioAMETEK, Inc. acquired LKC Technologies, a developer of electroretinography (ERG) diagnostic systems including the handheld RETeval® device. The acquisition strengthens AMETEK’s ophthalmology technology portfolio by adding retinal function assessment solutions used in clinical diagnostics and research applications.
November 2025 – Gaush Meditech Receives Medical Device Registration Approval for Ophthalmic Electrophysiological Diagnostic SystemGaush Meditech Ltd. received regulatory registration approval in China for its ophthalmic electrophysiological diagnostic system integrating electroretinography (ERG), visual evoked potential (VEP), and electrooculography (EOG) functions. The approval expands access to integrated retinal and visual pathway diagnostic solutions.
July 2025 – Nidek Advances Next-Generation ERG Diagnostic TechnologyNidek Co., Ltd. introduced advancements in stationary electroretinography systems featuring improved diagnostic capabilities and enhanced retinal testing performance. The company focused on integrating advanced analysis features to support ophthalmologists in detecting retinal disorders.
March 2025 – American Academy of Ophthalmology Includes ERG in Diabetic Retinopathy Clinical GuidanceAmerican Academy of Ophthalmology (AAO) incorporated electroretinography into its diabetic retinopathy clinical practice guidance, supporting broader recognition of ERG testing as a tool for evaluating retinal function in clinical settings.